RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+2.27%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$822M
AUM Growth
+$822M
(-1.8%)
Cap. Flow
+$5.83M
Cap. Flow
% of AUM
0.71%
Top 10 Holdings %
Top 10 Hldgs %
40.53%
Holding
68
New
13
Increased
13
Reduced
19
Closed
21
Top Buys
| 1 |
Medtronic
MDT
|
$37.6M |
| 2 |
Universal Health Services
UHS
|
$35.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$29.1M |
| 4 |
AGN
ALLERGAN INC
AGN
|
$28.5M |
| 5 |
Zimmer Biomet
ZBH
|
$26.6M |
Top Sells
| 1 |
Tenet Healthcare
THC
|
$33.8M |
| 2 |
Agilent Technologies
A
|
$24.5M |
| 3 |
Bristol-Myers Squibb
BMY
|
$21.7M |
| 4 |
Insulet
PODD
|
$21.7M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$19.8M |
Sector Composition
| 1 | Healthcare | 77.94% |
| 2 | Technology | 2% |
| 3 | Communication Services | 1.83% |
| 4 | Industrials | 1.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $39.4M | 4.78% | 176,698 -69,700 | -28% | -$15.5M |
|
|
2
Medtronic
MDT
$119B
| $37.6M | 4.56% | +589,974 | New | +$37.6M |
|
|
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
| $36.9M | 4.47% | 8,085,945 +3,203,015 | +66% | +$14.6M |
|
|
4
Universal Health Services
UHS
$11.6B
| $35.4M | 4.29% | +369,603 | New | +$35.4M |
|
5
HCA Healthcare
HCA
$94.5B
| $34.7M | 4.21% | 615,059 -257,530 | -30% | -$14.5M |
|
|
RCPT
6
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $32.1M | 3.89% | 753,660 +442,933 | +143% | +$18.9M |
|
|
CLVS
7
DELISTED
Clovis Oncology, Inc.
CLVS
| $30M | 3.64% | 723,816 +210,618 | +41% | +$8.72M |
|
|
CMRX
8
DELISTED
Chimerix, Inc.
CMRX
| $29.3M | 3.56% | 1,337,150 +442,144 | +49% | +$9.7M |
|
|
9
BioMarin Pharmaceuticals
BMRN
$11.2B
| $29.1M | 3.53% | +468,100 | New | +$29.1M |
|
|
AGN
10
DELISTED
ALLERGAN INC
AGN
| $28.8M | 3.5% | 170,400 +168,614 | +9,441% | +$28.5M |
|
11
Bausch Health
BHC
$2.74B
| $28.7M | 3.49% | 227,830 -69,306 | -23% | -$8.74M |
|
|
12
Zimmer Biomet
ZBH
$21B
| $26.6M | 3.23% | +256,053 | New | +$26.6M |
|
13
Amicus Therapeutics
FOLD
$2.34B
| $25.6M | 3.1% | 7,650,268 -846,270 | -10% | -$2.83M |
|
|
TRIV
14
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
| $22.1M | 2.69% | +1,540,648 | New | +$22.1M |
|
|
TVTY
15
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $21.7M | 2.63% | 1,234,771 -120,061 | -9% | -$2.11M |
|
|
KYTH
16
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $21.5M | 2.61% | 560,356 +117,030 | +26% | +$4.49M |
|
|
17
Agilent Technologies
A
$35.7B
| $19.9M | 2.42% | 346,880 -426,114 | -55% | -$24.5M |
|
18
Globus Medical
GMED
$8.27B
| $19.9M | 2.42% | 832,988 -229,964 | -22% | -$5.5M |
|
|
HTWR
19
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $19.7M | 2.39% | 222,926 -69,048 | -24% | -$6.11M |
|
20
Amgen
AMGN
$155B
| $19.3M | 2.34% | +163,254 | New | +$19.3M |
|
21
Stryker
SYK
$150B
| $18M | 2.19% | +213,918 | New | +$18M |
|
|
NUVA
22
DELISTED
NuVasive, Inc.
NUVA
| $17.9M | 2.17% | 502,291 -19,010 | -4% | -$676K |
|
|
RAD
23
DELISTED
Rite Aid Corporation
RAD
| $17.7M | 2.15% | 2,473,855 -1,327,945 | -35% | -$9.52M |
|
|
NSTG
24
DELISTED
NanoString Technologies, Inc.
NSTG
| $17M | 2.06% | 1,133,948 +605,878 | +115% | +$9.06M |
|
|
ITCI
25
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $16.5M | 2% | 979,446 -21,614 | -2% | -$364K |
|